Skip to main content
Clinical Trials/NL-OMON33614
NL-OMON33614
Completed
Not Applicable

Genetics and genomics of hypertension associated with microinflammation, oxidative stress, chronic renal disease and heart failure. - InGenious HyperCare

Interne Geneeskunde0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
essential hypertension
Sponsor
Interne Geneeskunde
Enrollment
200
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Interne Geneeskunde

Eligibility Criteria

Inclusion Criteria

  • \- Men or women between 18 and 60 years of age at time of enrolment
  • \- Essential hypertension diagnosed before the age of 50 years.
  • \- At least 3 first\-degree relatives of whom at least 1 should have hypertension and at least one from a different generation, willing to participate in the study.
  • \- Written informed consent

Exclusion Criteria

  • \- Any known form of secondary hypertension,
  • \- Any known previous clinical complications of hypertension (angina, myocardial infarction, stroke, TIA, peripheral artery disease) at any time
  • \- known renal disease, including GFR \< 60 mL/min/1\.73 m2 as estimated by the abbreviated MDRD formula, or kidney stones
  • \- Kidney or other organ transplantation
  • \- Type 1 diabetes mellitus
  • \- Heart failure stage D (AHA/ACC criteria)
  • \- Any malignant concomitant diseases or history of malignant diseases within the last five years, with exception of treated squamous skin cancer or basalioma
  • \- Clinical or laboratory signs of acute infection.
  • \- Systemic inflammatory diseases,
  • \- Steroids or any other immunosuppressive drug

Outcomes

Primary Outcomes

Not specified

Similar Trials